Persistent URL of this record https://hdl.handle.net/1887/3182980
Documents
-
- Download
- 176.full
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
- All authors
- Dougados, M.; Wei, J.C.C.; Landewe, R.; Sieper, J.; Baraliakos, X.; Bosch, F. van den; Maksymowych, W.P.; Ermann, J.; Walsh, J.A.; Tomita, T.; Deodhar, A.; Heijde, D. van der; Li, X.Q.; Zhao, F.Y.; Bertram, C.C.; Gallo, G.; Carlier, H.; Gensler, L.S.; COAST-V Study Grp; COAST-W Study Grp
- Date
- 2020-02-01
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 79
- Issue
- 2
- Pages
- 176 - 185